Alvogen announced a voluntary, consumer level recall of one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Classification Type: Class 1 Recall
Optum Clinical Services has sent a drug recall notification to potentially impacted members and providers. Below are the notification details.
|
Product
|
fentanyl transdermal system 25 mcg/h
|
|
Manufacturer
|
Alvogen
|
|
Recall Identification date
|
02/03/2025
|
|
Affected NDCs
|
47781-424-47
|
|
Look back period
|
10/24/24 – 01/31/25
|
|
Target population for clinical mailing
|
All
|
|
Messaging type
|
Mailing/Phone: Members; Direct Message/Fax: Providers
|
|
Data release
|
SS00005114
|
|
Fulfillment due date for NCQA compliance
|
On or before: 02/23/2025
|
|
WHA impacted members
|
2 members
|
|
Date letters were mailed out
|
2/11/2025
|
Last review date: August 5, 2025